Kobayashi Pharmaceutical Co Ltd
TSE:4967

Watchlist Manager
Kobayashi Pharmaceutical Co Ltd Logo
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Watchlist
Price: 5 632 JPY -0.09%
Market Cap: ¥418.7B

Relative Value

The Relative Value of one Kobayashi Pharmaceutical Co Ltd stock under the Base Case scenario is 4 104.13 JPY. Compared to the current market price of 5 632 JPY, Kobayashi Pharmaceutical Co Ltd is Overvalued by 27%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
4 104.13 JPY
Overvaluation 27%
Relative Value
Price
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Kobayashi Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Kobayashi Pharmaceutical Co Ltd
TSE:4967
418.7B JPY 2.5 114.5 14.7 23.3
FR
L'Oreal SA
PAR:OR
186B EUR 4.2 30.5 18.5 22.5
UK
Unilever PLC
LSE:ULVR
106.5B GBP 2.4 12.9 12.5 14.2
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.1T INR 7.9 35.2 33.8 37.4
UK
HALEON PLC
LSE:HLN
34.3B GBP 3.1 20.6 14.4 16.5
US
Estee Lauder Companies Inc
NYSE:EL
31.8B USD 2.2 -178.6 16.2 25.6
DE
Beiersdorf AG
XETRA:BEI
16.9B EUR 1.7 18 8.5 10.6
JP
Kao Corp
TSE:4452
2.8T JPY 1.6 23.2 10.6 16.2
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.1T INR 7 58.6 35.3 38.6
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD 855.7 -4 624.4 -6 373.4 -6 360.4
IN
Dabur India Ltd
NSE:DABUR
816.4B INR 6.3 44.3 32.3 39.8
P/E Multiple
Earnings Growth PEG
JP
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Average P/E: 39.8
114.5
74%
1.5
FR
L'Oreal SA
PAR:OR
30.5
13%
2.3
UK
Unilever PLC
LSE:ULVR
12.9
-6%
N/A
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
35.2
7%
5
UK
HALEON PLC
LSE:HLN
20.6
11%
1.9
US
Estee Lauder Companies Inc
NYSE:EL
Negative Multiple: -178.6 N/A N/A
DE
Beiersdorf AG
XETRA:BEI
18
10%
1.8
JP
Kao Corp
TSE:4452
23.2
10%
2.3
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
58.6
18%
3.3
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -4 624.4 N/A N/A
IN
Dabur India Ltd
NSE:DABUR
44.3
11%
4
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
JP
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Average EV/EBITDA: 19.7
14.7
13%
1.1
FR
L'Oreal SA
PAR:OR
18.5
8%
2.3
UK
Unilever PLC
LSE:ULVR
12.5
4%
3.1
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
33.8
7%
4.8
UK
HALEON PLC
LSE:HLN
14.4
7%
2.1
US
Estee Lauder Companies Inc
NYSE:EL
16.2
16%
1
DE
Beiersdorf AG
XETRA:BEI
8.5
6%
1.4
JP
Kao Corp
TSE:4452
10.6
8%
1.3
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
35.3
12%
2.9
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -6 373.4 N/A N/A
IN
Dabur India Ltd
NSE:DABUR
32.3
11%
2.9
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
JP
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Average EV/EBIT: 24.5
23.3
N/A N/A
FR
L'Oreal SA
PAR:OR
22.5
9%
2.5
UK
Unilever PLC
LSE:ULVR
14.2
4%
3.5
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
37.4
8%
4.7
UK
HALEON PLC
LSE:HLN
16.5
8%
2.1
US
Estee Lauder Companies Inc
NYSE:EL
25.6
26%
1
DE
Beiersdorf AG
XETRA:BEI
10.6
7%
1.5
JP
Kao Corp
TSE:4452
16.2
N/A N/A
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
38.6
13%
3
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -6 360.4 N/A N/A
IN
Dabur India Ltd
NSE:DABUR
39.8
11%
3.6
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett